The Dermatology Life Quality Index (DLQI) is the most widely used tool for assessing dermatology-related quality of life (QoL).
The DLQI-Relevant (DLQI-R) incorporates ‘not relevant’ responses (NRR) into the scoring, preventing underestimation of disease impact, common in elderly patients with psoriasis (Pso), however further evidence is needed to support its use into clinical practice. We assessed the convenience of the DLQI-R and its correlation with disease severity in this population.